Fallon, B.A., Keilp, J.G., Corbera, K.M., et al. (2008) A Randomized, Placebo-Controlled Trial of Repeated IV Antibiotic Therapy for Lyme Encephalopathy. Neurology, 70, 992-1003.
https://doi.org/10.1212/01.WNL.0000284604.61160.2d

has been cited by the following article:

• TITLE: Antabuse for Lyme Disease: The Way Forward

  AUTHORS: David S. Younger, Beverley F. Murphy

  KEYWORDS: Disulfiram, Antabuse, Lyme Disease, Immune Globulin Therapy

  JOURNAL NAME: World Journal of Neuroscience, Vol.10 No.1, November 29, 2019

  ABSTRACT: Despite leadership by dedicated lay organization and patient-based advocacy groups, the way forward for prospective candidates for disulfiram treatment has been difficult. This article provides the background, overview of disulfiram, in particular its intended use in post-treatment Lyme disease syndrome after a standard of care course of antibiotics fails to alleviate symptoms of tick borne disease. A series of recommendations are offered to guide patients and clinicians.